Hui Ping Wu
Director/Board Member at XinYu Pharmaceutical Co., Ltd.
Profile
Hui Ping Wu is an Independent Director at XinYu Pharmaceutical Co., Ltd.
since 2016.
Prior to this, Wu was an Independent Director at Shanghai Tongda Venture Capital Co., Ltd.
Hui Ping Wu active positions
| Companies | Position | Start |
|---|---|---|
XinYu Pharmaceutical Co., Ltd.
 XinYu Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Xinyu Pharmaceutical Co., Ltd. engages in the research, development, and production of microbial pharmaceuticals. Its key products are the active pharmaceutical ingredient lincomycin hydrochlorlde and its derivatives, which include clindamycin hydrochloride and clindamycin phosphate, as well as neomycin sulphate, moxidectin, framycetin sulphate, tenofovir disoproxil fumarate, nosihepitde premix, and enramycin premix. The company was founded in 1988 and is headquartered in Suzhou, China. | Director/Board Member | 2016-11-30 |
Former positions of Hui Ping Wu
| Companies | Position | End |
|---|---|---|
| SHANGHAI TONGDA VENTURE CAPITAL CO., LTD. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SHANGHAI TONGDA VENTURE CAPITAL CO., LTD. | Finance |
| Private companies | 1 |
|---|---|
XinYu Pharmaceutical Co., Ltd.
XinYu Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Xinyu Pharmaceutical Co., Ltd. engages in the research, development, and production of microbial pharmaceuticals. Its key products are the active pharmaceutical ingredient lincomycin hydrochlorlde and its derivatives, which include clindamycin hydrochloride and clindamycin phosphate, as well as neomycin sulphate, moxidectin, framycetin sulphate, tenofovir disoproxil fumarate, nosihepitde premix, and enramycin premix. The company was founded in 1988 and is headquartered in Suzhou, China. | Health Technology |
- Stock Market
- Insiders
- Hui Ping Wu
